$883.20
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NasdaqGS:REGN
Regeneron Pharmaceuticals Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$13.12B | $12.17B | $16.07B | $174.02M | $66.19M | $63.45M | $125.02M | $238.46M | $379.27M | $459.07M | $445.82M | $1.38B | $2.10B | $2.82B | $4.10B | $4.86B | $5.87B | $5.15B | $6.56B | $8.31B | |
| GM % | Gross Margin % |
|
52.32% | 57.67% | 66.74% | 13.05% | -124.43% | -128.87% | -61.94% | -15.67% | -5.58% | -7.03% | -19.72% | 48.49% | 51.76% | 47.64% | 50.94% | 51.61% | 57.90% | 63.34% | 50.97% | 53.61% | |
| OM | Operating Margin |
|
32.27% | 41.03% | 55.67% | 3.24% | -184.62% | -169.68% | -92.28% | -36.17% | -19.54% | -21.23% | -46.02% | 33.20% | 35.30% | 29.22% | 30.51% | 27.38% | 35.41% | 49.25% | 34.24% | 39.65% | |
| EPS | Earnings Per Share |
|
$0.00 | $43.79 | $44.98 | $74.66 | $31.47 | $24.67 | $22.84 | $16.32 | $11.32 | $12.07 | $10.00 | $8.17 | $4.66 | $-2.45 | $-1.26 | $-0.85 | $-1.05 | $-1.59 | $-1.77 | $-1.90 | $0.20 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0 | -0.00% | -0.00% | -0.00% | 0 | -0.00% | -0.00% | -0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Sha. | Shares |
|
107.12m | 107m | 106.57m | 55.86m | 56.44m | 65.4m | 78.85m | 79.39m | 80.61m | 88.58m | 92.05m | 96.65m | 99.15m | 101.88m | 104.11m | 105.46m | 107.52m | 108.53m | 109.12m | 103.96m | |
| OCF | Operating Cash Flow |
|
$4.59B | $5.01B | $7.08B | $-16.91M | $-30.30M | $23.08M | $27.37M | $-89.09M | $-69.94M | $99.22M | $-141.68M | $-74.62M | $588.60M | $752.44M | $1.33B | $1.49B | $1.31B | $2.20B | $2.43B | $2.62B | |
| FCF | Free Cash Flow |
|
$5.65B | $4.42B | $6.53B | $-23.08M | $-35.26M | $20.27M | $8.92M | $-123.95M | $-167.26M | $-3.35M | $-198.90M | $-123.95M | $427.33M | $410.15M | $652.85M | $961.46M | $1.03B | $1.81B | $2.00B | $2.00B | |
| FCFS | Free Cash Flow Per Share |
|
$34.37 | $31.73 | $61.77 | $-0.42 | $-0.63 | $0.35 | $0.13 | $-1.57 | $-2.10 | $-0.01 | $-2.20 | $-1.31 | $4.41 | $4.17 | $6.33 | $9.30 | $9.73 | $16.79 | $18.32 | $18.62 |
